Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Indication of the Parent Protocol
Suwon, Gyeonggi-do
Indication of the Parent Protocol Clinical Trials in Suwon, Gyeonggi-do
1 recruiting
Suwon, Gyeonggi-do, South Korea
Showing
1–1
of
1
trials
Recruiting
Phase 3
Remibrutinib Open Label Roll-over Post-trial Access Protocol
Indication of the Parent Protocol
Novartis Pharmaceuticals
648 enrolled
33 locations
NCT07456891
Feedback